MedTrace Logo

Micropulse 577 nm Laser Photocoagulation Versus Conventional 532 nm Laser Photocoagulation for Diabetic Macular Oedema

NCT01045239 · Status: UNKNOWN · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2010-01-08

No results posted yet for this study

Summary

The purpose of this study is to determine whether the new micropulse 577 nm yellow laser is a better treatment option compared to the conventional 532 nm green laser for diabetic macular edema.

Conditions

Interventions

DEVICE

Micropulse 577 nm yellow diode laser

Laser administered at beginning of study and may be repeated at 16 weeks if needed

DEVICE

532 nm green diode laser

Laser administered at beginning of study and may be repeated at 16 weeks if needed

Sponsors & Collaborators

  • University of Malaya

    lead OTHER

Principal Investigators

  • Kenneth C Fong, FRCOphth · University of Malaya Eye Research Centre

  • Tajunisah Iqbal, FRCS · University of Malaya Eye Research Centre

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-10-31
Primary Completion
2011-10-31
Completion
2012-01-31

Countries

  • Malaysia

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01045239 on ClinicalTrials.gov